Assessing the state of knowledge regarding the effectiveness of interventions to contain pandemic influenza transmission: A systematic review and narrative synthesis

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Saunders Hastings, Patrick ^a   Reisman, Jane ^a   Krewski, Daniel ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL THERAPY; CROSS PROTECTION; DISEASE TRANSMISSION; HEALTH CARE POLICY; HUMAN; INFLUENZA VACCINATION; INTERVENTION STUDY; LIMIT OF QUANTITATION; MASS SCREENING; PANDEMIC INFLUENZA; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PROTECTIVE EQUIPMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEASONAL INFLUENZA; SYSTEMATIC REVIEW; TRADITIONAL MEDICINE; INFECTION CONTROL; INFLUENZA, HUMAN; KNOWLEDGE; MEASUREMENT ACCURACY; META ANALYSIS; PANDEMICS; PROCEDURES; TREATMENT OUTCOME;

INFLUENZA VACCINE;

DATA ACCURACY; HUMANS; INFECTION CONTROL; INFLUENZA VACCINES; INFLUENZA, HUMAN; KNOWLEDGE; PANDEMICS; TREATMENT OUTCOME;

EID: 85006251477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168262     Document Type: Review

References (77)

1. Longini IM Jr. A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research. Pediatrics. 2012; 129 Suppl 2:S63-7. Epub 2012/03/06.
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25(27):5086-96. Epub 2007/06/05. doi: 10.1016/j.vaccine.2007.03.046 PMID: 17544181
3. Waring J. A history of medicine in South Carolina. South Carolina Medical Association 1971.
4. Jordan EO. Epidemic influenza: a survey. Chicago, IL: American Medical Association; 1927.
5. Patterson KD, Pyle GF. The geography and mortality of the 1918 influenza pandemic. Bulletin of the History of Medicine. 1991; 65(1):4-21. PMID: 2021692
6. Johnson N, Mueller J. Updating the accounts: Global mortality of the 1918-1920 "Spanish" influenza pandemic. Bulletin of the History of Medicine. 2002; 76(1):105-15. PMID: 11875246
7. Humphries M. Paths of infection: The First World War and the origins of the 1918 influenza pandemic. War in History. 2013; 21(1):55-81.
8. Cruz AT, Tittle KO, Smith ER, Sirbaugh PE. Increasing out-of-hospital regional surge capacity for H1N1 2009 influenza a through existing community pediatrician offices: a qualitative description of quality improvement strategies. Disaster Medicine and Public Health Preparedness; Special issue. 2012; 6(2): 113-6.
9. Nap R, Andriessen P, Meesen N, Werf T. Pandemic influenza and hospital resources. Emerging Infectious Diseases. 2007; 13(11):1714-9. doi: 10.3201/eid1311.070103 PMID: 18217556
10. Meltzer MI, Patel A, Ajao A, Nystrom SV, Koonin LM. Estimates of the demand for mechanical ventilation in the United States during an influenza pandemic. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2015; 60 Suppl 1:S52-7.
11. Barbisch DF, Koenig KL. Understanding Surge Capacity: Essential Elements. Academic Emergency Medicine. 2006; 13(11):1098-102. doi: 10.1197/j.aem.2006.06.041 PMID: 17085738
12. Schultz CH, Koenig KL. State of Research in High-consequence Hospital Surge Capacity. Academic Emergency Medicine. 2006; 13(11):1153-6. doi: 10.1197/j.aem.2006.06.033 PMID: 16946288
13. Jiao HU XL. Endemicity of H9N2 and H5N1 avian influenza viruses in poultry in China poses a serious threat to poultry industry and public health. Front Agr Sci Eng. 2016; 3(1):11-24.
14. Li X, Zhang Z, Yu A, Ho SYW, Carr MJ, Zheng W. Global and local persistence of influenza A(H5N1) virus. Emerging Infectious Diseases. 2014; 20(8):1287-95. doi: 10.3201/eid2008.130910 PMID: 25061965
15. Watson SJ, Langat P, Reid SM, Lam TT-Y, Cotten M, Kelly M, et al. Molecular Epidemiology and Evolution of Influenza Viruses Circulating within European Swine between 2009 and 2013. Journal of Virology. 2015; 89(19):9920-31. doi: 10.1128/JVI.00840-15 PMID: 26202246
16. Murray KA, Allen T, Loh E, Machalaba C, Daszak P. Emerging Viral Zoonoses from Wildlife Associated with Animal-Based Food Systems: Risks and Opportunities. In: Jay-Russell M, Doyle PM, editors. Food Safety Risks from Wildlife: Challenges in Agriculture, Conservation, and Public Health. Cham: Springer International Publishing; 2016. p. 31-57.
17. Hollenbeck JE. Interaction of the role of Concentrated Animal Feeding Operations (CAFOs) in Emerging Infectious Diseases (EIDS). Infection, Genetics and Evolution. 2016; 38:44-6. http://dx.doi.org/10.1016/j.meegid.2015.12.002. PMID: 26656834
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement. PLos Medicine. 2009; 6(7):e1000097. doi: 10.1371/journal.pmed.1000097 PMID: 19621072
19. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007; 7:10. doi: 10.1186/1471-2288-7-10 PMID: 17302989
20. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009; 62(10):1013-20. doi: 10.1016/j.jclinepi.2008.10.009 PMID: 19230606
21. Malik VS, Hu FB. Sugar-sweetened beverages and health: where does the evidence stand? The American Journal of Clinical Nutrition. 2011; 94(5):1161-2. doi: 10.3945/ajcn.111.025676 PMID: 21993436
22. Bahia L, Coutinho ESF, Barufaldi LA, de Azevedo Abreu G, Malhão TA, Ribeiro de Souza CP, et al. The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study. BMC public health. 2012; 12(1):1-7.
23. Remschmidt C, Wichmann O, Harder T. Methodological quality of systematic reviews on influenza vaccination. Vaccine. 2014; 32(15):1678-84. http://dx.doi.org/10.1016/j.vaccine.2014.01.060. PMID: 24513008
24. Michiels B, Van Puyenbroeck K, Verhoeven V, Vermeire E, Coenen S. The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews. PloS one. 2013; 8(4):e60348. doi: 10.1371/journal.pone.0060348 PMID: 23565231
25. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011; 29(49):9159-70. http://dx.doi.org/10.1016/j.vaccine.2011.08.008. PMID: 21840359
26. Breteler JK, Tam JS, Jit M, Ket JC, De Boer MR. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and metaanalysis. Vaccine. 2013; 31(45):5168-77. doi: 10.1016/j.vaccine.2013.08.056 PMID: 24012574
27. Chien YW, Klugman KP, Morens DM. Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. Journal of Infectious Diseases. 2010; 202(11): 1639-48. doi: 10.1086/657144 PMID: 21028954
28. Demicheli V, Jefferson T, Al-Ansary Lubna A, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews [Internet]. 2014; (3:). Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001269.pub5/abstract http://onlinelibrary.wiley.com/store/10.1002/14651858.CD001269.pub5/asset/CD001269.pdf?v=1&t=ir6by811&s=02e43e5110d2a788f3e1c4fe190b9f1808bafd70.
29. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews. 2014;(8:):N.PAG-N.PAG 1p. Language: English. Entry Date: 20101029. Revision Date: 20150711. Publication Type: Journal Article.
30. Manzoli L, De Vito C, Salanti G, D'Addario M, Villari P, Ioannidis JP. Meta-analysis of the immunogenic-tyand tolerability of pandemic influenza A 2009 (H1N1) vaccines. PloS one. 2011; 6(9):e24384. Epub 2011/09/15. doi: 10.1371/journal.pone.0024384 PMID: 21915319
31. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2012; 12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X PMID: 22032844
32. Yin JK, Chow MYK, Khandaker G, King C, Richmond P, Heron L, et al. Impacts on influenza A(H1N1) pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses. Vaccine. 2012; 30(21):3209-22. doi: 10.1016/j.vaccine.2012.02.048 PMID: 22387221
33. Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R. Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: Systematic review and meta-analysis. Influenza and other respiratory viruses. 2011; 5(5):299-305. doi: 10.1111/j.1750-2659.2011.00229.x PMID: 21668694
34. Fielding JE, Kelly HA, Mercer GN, Glass K. Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age. Influenza and other respiratory viruses. 2014; 8(2): 142-50. Epub 2013/12/05. doi: 10.1111/irv.12216 PMID: 24299099
35. Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Amantadine and rimantadine for influenza A in adults. Cochrane Database of Systematic Reviews [Internet]. 2008; (2:). Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001169.pub3/abstract http://onlinelibrary.wiley.com/store/10.1002/14651858.CD001169.pub3/asset/CD001169.pdf?v=1&t=ir6bylaj&s=b0aacaf87cdd4dc2312ad17684d1317203e2b03b.
36. Mizumoto K, Nishiura H, Yamamoto T. Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review. Theor Biol Med Model. 2013; 10:4. Epub 2013/01/18. doi: 10.1186/1742-4682-10-4 PMID: 23324555
37. Li ZY, Chen JY, Zhang YL, Fu WM. Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and metaanalyses. Human Vaccines Immunother. 2015; 11(6):1337-44.
38. Mukerji S, MacIntyre CR, Newall AT. Review of economic evaluations of mask and respirator use for protection against respiratory infection transmission. BMC infectious diseases. 2015; 15:413. Epub 2015/10/16. doi: 10.1186/s12879-015-1167-6 PMID: 26462473
39. Wong VWY, Cowling BJ, Aiello AE. Hand hygiene and risk of influenza virus infections in the community: A systematic review and meta-analysis. Epidemiology and Infection. 2014; 142(5):922-32. doi: 10.1017/S095026881400003X PMID: 24572643
40. Jackson C, Vynnycky E, Hawker J, Olowokure B, Mangtani P. School closures and influenza: Systematic review of epidemiological studies. BMJ open. 2013; 3(2) (no pagination)(002149).
41. Li JH, Wang RQ, Guo WJ, Li JS. Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): A meta-analysis. Journal of the Chinese Medical Association: JCMA. 2016; 79(5): 281-91. doi: 10.1016/j.jcma.2015.10.009 PMID: 26935853
42. Perez Velasco R, Praditsitthikorn N, Wichmann K, Mohara A, Kotirum S, Tantivess S, et al. Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PloS one. 2012; 7(2):e30333. Epub 2012/03/07. doi: 10.1371/journal.pone.0030333 PMID: 22393352
43. Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, et al. Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing. New England Journal of Medicine. 2010; 363(25):2416-23. doi: 10.1056/NEJMoa1006736 PMID: 21158658
44. Yamada T, Yamada T, Morikawa M, Cho K, Endo T, Sato SS, et al. Pandemic (H1N1) 2009 in pregnant Japanese women in Hokkaido. The journal of obstetrics and gynaecology research. 2012; 38(1):130-6. Epub 2011/10/01. doi: 10.1111/j.1447-0756.2011.01644.x PMID: 21955086
45. Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011; 52(10):1203-11. Epub 2011/04/22.
46. Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, et al. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Pediatrics. 2011; 128(5): e1084-91. Epub 2011/10/12. doi: 10.1542/peds.2010-3492 PMID: 21987710
47. Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. Vaccine. 2011; 29(45):7975-81. Epub 2011/09/03. doi: 10.1016/j.vaccine.2011.08.068 PMID: 21884747
48. Van Buynder PG, Dhaliwal JK, Van Buynder JL, Couturier C, Minville-Leblanc M, Garceau R, et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza and other respiratory viruses. 2010; 4(4):171-8. Epub 2010/07/16. doi: 10.1111/j.1750-2659.2010.00146.x PMID: 20629771
49. Valenciano M, Kissling E, Cohen J-M, Oroszi B, Barret A-S, Rizzo C, et al Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009-2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study. PLoS Med. 2011; 8(1):e1000388. doi: 10.1371/journal.pmed.1000388 PMID: 21379316
50. Mogabgab WJ, Leiderman E. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. Jama. 1970; 211(10):1672-6. Epub 1970/03/09. PMID: 4984268
51. Suess T, Remschmidt C, Schink S, Luchtenberg M, Haas W, Krause G, et al. Facemasks and intensified hand hygiene in a German household trial during the 2009/2010 influenza A(H1N1) pandemic: adherence and tolerability in children and adults. Epidemiol Infect. 2011; 139(12):1895-901. Epub 2011/01/08. doi: 10.1017/S0950268810003006 PMID: 21211103
52. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. The Cochrane database of systematic reviews. 2011;(7:):Cd006207. Epub 2011/07/08. doi: 10.1002/14651858.CD006207.pub4 PMID: 21735402
53. Torner N, Soldevila N, Garcia JJ, Launes C, Godoy P, Castilla J, et al. Effectiveness of non-pharmaceutical measures in preventing pediatric influenza: a case-control study. BMC public health. 2015; 15:543. Epub 2015/06/10. doi: 10.1186/s12889-015-1890-3 PMID: 26055522
54. Suess T, Remschmidt C, Schink S, Luchtenberg M, Haas W, Krause G, et al. Facemasks and intensified hand hygiene in a German household trial during the 2009/2010 influenza A(H1N1) pandemic: adherence and tolerability in children and adults. Epidemiology and infection. 2011; 139(12):1895-901. doi: 10.1017/S0950268810003006 PMID: 21211103
55. Thomas Roger E, Lorenzetti Diane L. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database of Systematic Reviews [Internet]. 2014; (7:). Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005188.pub3/abstract http://onlinelibrary.wiley.com/store/10.1002/14651858.CD005188.pub3/asset/CD005188.pdf?v=1&t=ir6c06k5&s=3382482ed0f8dff440f6910a1d4115f85c83b825.
56. Cowling BJ, Chan KH, Fang VJ, Cheng CK, Fung RO, Wai W, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Annals of internal medicine. 2009; 151(7):437-46. Epub 2009/08/05. PMID: 19652172
57. Lau JT, Yang X, Tsui H, Kim JH. Monitoring community responses to the SARS epidemic in Hong Kong: from day 10 to day 62. Journal of epidemiology and community health. 2003; 57(11):864-70. Epub 2003/11/06. doi: 10.1136/jech.57.11.864 PMID: 14600111
58. Lowen A, Palese P. Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contact: A hypothesis. PLoS Currents. 2009; 1:RRN1002. doi: 10.1371/currents.RRN1002 PMID: 20025197
59. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database of Systematic Reviews. 2014b;(4:):N.PAG-N.PAG 1 p Language: English. Entry Date: 20110325. Revision Date: 20151007. Publication Type: Journal Article.
60. Madhav N. Modelling a modern-day spanish flu pandemic. 2013.
61. Longini I, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. American Journal of Epidemiology. 2004; 159:623-33. PMID: 15033640
62. Mitchell MD, Mikkelsen ME, Umscheid CA, Lee I, Fuchs BD, Halpern SD. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Critical Care Medicine. 2010; 38(6):1398-404. doi: 10.1097/CCM.0b013e3181de45db PMID: 20400902
63. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. Journal of Infectious Diseases. 2013; 207(4):553-63. doi: 10.1093/infdis/jis726 PMID: 23204175
64. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. The Lancet Respiratory Medicine. 2014; 2(5):395-404. doi: 10.1016/S2213-2600(14)70041-4 PMID: 24815805
65. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun A, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data metaanalysis. Influenza and other respiratory viruses. 2016; 10(3):192-204. doi: 10.1111/irv.12363 PMID: 26602067
66. Ortiz JR, Rudd KE, Clark DV, Jacob ST, West TE. Clinical research during a public health emergency: a systematic review of severe pandemic influenza management. Critical Care Medicine. 2013; 41(5): 1345-52. doi: 10.1097/CCM.0b013e3182771386 PMID: 23399939
67. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam JS, Lim WS. Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. Journal of Infectious Diseases. 2015; 212(2):183-94. doi: 10.1093/infdis/jiu645 PMID: 25406333
68. Rudd KE, Ortiz JR, Clark DV, Jacob ST, West TE. A systematic review of clinical interventions for patients with severe pandemic influenza a (H1N1) virus infection. American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS. 2012; 185 (no pagination).
69. Venkatesan S, Myles PR, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of outpatient neuraminidase inhibitor treatment on hospitalisation in patients infected with influenza A (H1N1)pdm09: An IPD analysis. International Journal of Infectious Diseases. 2016; 45:248.
70. Yang JW, Fan LC, Miao XY, Mao B, Li MH, Lu HW, et al. Corticosteroids for the treatment of human infection with influenza virus: A systematic review and meta-analysis. Clinical Microbiology and Infection. 2015; 21(10):956-63. doi: 10.1016/j.cmi.2015.06.022 PMID: 26123860
71. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun A, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data metaanalysis. Influenza & Other Respiratory Viruses. 2016; 10(3):192-204.
72. Bitar D, Goubar A, Desenclos JC. International travels and fever screening during epidemics: a literature review on the effectiveness and potential use of non-contact infrared thermometers. Eurosurveillance. 2009; 14(6). Epub 2009/02/14.
73. Nishiura H, Kamiya K. Fever screening during the influenza (H1N1-2009) pandemic at Narita International Airport, Japan. BMC infectious diseases. 2011; 11(1):111.
74. Hale MJ, Hoskins RS, Baker MG. Screening for Influenza A(H1N1)pdm09, Auckland International Airport, New Zealand. Emerging Infectious Diseases. 2012; 18(5):866-8. doi: 10.3201/eid1805.111080 PMID: 22516105
75. Yu H, Cauchemez S, Donnelly CA, Zhou L, Feng L, Xiang N, et al. Transmission Dynamics, Border Entry Screening, and School Holidays during the 2009 Influenza A (H1N1) Pandemic, China. Emerging Infectious Diseases. 2012; 18(5):758-66. doi: 10.3201/eid1805.110356 PMID: 22515989
76. Cowling BJ, Lau LL, Wu P, Wong HW, Fang VJ, Riley S, et al. Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC infectious diseases. 2010; 10(1):82.
77. Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Medical Research Methodology. 2011; 11(1):1-6.